Skip to main content

Paratek Pharmaceuticals, Inc.

PRTKDelisted Sep 21, 2023
Industry
Pharmaceutical Preparations
SEC CIK
0001178711

Paratek Pharmaceuticals, Inc. was delisted on Sep 21, 2023; its insiders filed their last Form 4 on Sep 21, 2023; 66 institutions reported holding it in 13F filings for Q2 2023, worth $47.0M in total; no superinvestor held it.

13F holders, Q2 2022

Institutional positions in Paratek Pharmaceuticals, Inc. as of Jun 30, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works

Institutional holders
84
−14 vs. Q1 2022
Shares held
22.8M
−4.79M (−17.4%) vs. Q1 2022
Total value
$44.4M
−$37.4M (−45.7%) vs. Q1 2022
New holders
14
21 more added
Sold out
28
31 more reduced

2 institutions that held it in Q1 2022 haven't filed for Q2 2022 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.

Compare with Q1 2022: new holders, sold out and not filed yet

Holders and value by quarter

Institutions reporting PRTK on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.

Institutional holdersQ2 2022: 84 institutions
Q1 2021: 107 institutionsQ2 2021: 116 institutionsQ3 2021: 105 institutionsQ4 2021: 103 institutionsQ1 2022: 100 institutionsQ2 2022: 84 institutionsQ3 2022: 72 institutionsQ4 2022: 76 institutionsQ1 2023: 63 institutionsQ2 2023: 66 institutionsQ3 2023: 0 institutionsQ4 2023: 0 institutionsQ1 2024: 0 institutionsQ2 2024: 0 institutionsQ3 2024: 0 institutionsQ4 2024: 0 institutionsQ1 2025: 0 institutionsQ2 2025: 0 institutionsQ3 2025: 0 institutionsQ4 2025: 0 institutionsQ1 2026: 0 institutionsQ2 2026: 0 institutions
Value heldQ2 2022: $44.4M
Q1 2021: $169.4MQ2 2021: $166.5MQ3 2021: $116.5MQ4 2021: $114.1MQ1 2022: $82.1MQ2 2022: $44.4MQ3 2022: $59.8MQ4 2022: $42.6MQ1 2023: $59.1MQ2 2023: $47.0MQ3 2023: $0Q4 2023: $0Q1 2024: $0Q2 2024: $0Q3 2024: $0Q4 2024: $0Q1 2025: $0Q2 2025: $0Q3 2025: $0Q4 2025: $0Q1 2026: $0Q2 2026: $0
Institutions holding PRTK and their total value by quarter
QuarterHoldersValue
Q2 20260$0
Q1 20260$0
Q4 20250$0
Q3 20250$0
Q2 20250$0
Q1 20250$0
Q4 20240$0
Q3 20240$0
Q2 20240$0
Q1 20240$0
Q4 20230$0
Q3 20230$0
Q2 202366$47.0M
Q1 202363$59.1M
Q4 202276$42.6M
Q3 202272$59.8M
Q2 202284$44.4M
Q1 2022100$82.1M
Q4 2021103$114.1M
Q3 2021105$116.5M
Q2 2021116$166.5M
Q1 2021107$169.4M

Institutions, Q2 2022

Shares, value and share of portfolio for each institution holding Paratek Pharmaceuticals, Inc.; share changes are against Q1 2022.

Institutions holding PRTK in Q2 2022
InstitutionSharesValue% of portfolioChange in sharesAction
Barclays PLC0$00.00%−7,952−100.0%Sold out
Amalgamated Bank0$00.00%−7,975−100.0%Sold out
Legal & General Group Plc0$00.00%−4,978−100.0%Sold out
Ameritas Investment Partners, Inc.0$00.00%−3,554−100.0%Sold out
Aquatic Capital Management LLC0$00.00%−3,000−100.0%Sold out
Bollard Group LLC0$00.00%−2,159−100.0%Sold out
Point72 Hong Kong Ltd0$00.00%−1,651−100.0%Sold out
Simplex Trading, LLC0$00.00%−1,426−100.0%Sold out
The PNC Financial Services Group, Inc.0$00.00%−392−100.0%Sold out
McCarthy Asset Management, Inc.0$00.00%−800−100.0%Sold out
Montag A & Associates Inc0$00.00%−100−100.0%Sold out
FinTrust Capital Advisors, LLC0$00.00%−74−100.0%Sold out
Parametric Portfolio Associates LLC––––Not filed
Amalgamated Financial Corp.––––Not filed